# Probiotic Gut Barrier Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/probiotic-gut-barrier-meta-analysis-evidence-review
Category: evidence-review
Summary: Probiotic Gut Barrier Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mix
Last reviewed: 2026-06-08
Reviewed by: Migaku Evidence Review
# Probiotic Gut Barrier Meta-analysis: What the Evidence Says

## Quick Answer

Probiotic Gut Barrier Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Unraveling the intricate link: gut microbiota and recurrent spontaneous abortion | narrative review | 3 | 2026-05-21 | 10.3389/frph.2026.1801173 |
| Probiotics and the Human Microbiome: Classical Functions, Emerging Systemic Roles, and Future Therapeutic Frontiers | narrative review | 3 | 2026-04-23 | 10.3390/biology15090665 |

## What The Sources Report

- It is estimated that approximately 1% to 5% of couples of reproductive age experience RSA, with the risk increasing with advanced maternal age and the number of previous miscarriages (-). [Li Dan (2026); evidence level 3]
- RSA not only causes physical harm, such as uterine damage and increased risk of infection, but also leads to severe psychological stress, including depression, anxiety, and infertility-related distress. [Li Dan (2026); evidence level 3]
- This review adopts a systems-level perspective to synthesize emerging evidence on probiotic-driven gut-brain, gut-skin, gut-oral, and metabolic interactions, emphasizing shared mechanisms rather than isolated clinical outcomes. [Zalila-Kolsi Imen (2026); evidence level 3]
- In parallel, advances in encapsulation and delivery technologies have improved probiotic survival during gastrointestinal transit, thereby enhancing their functional efficacy within the gut. [Zalila-Kolsi Imen (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For probiotic gut barrier meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Li Dan (2026). Unraveling the intricate link: gut microbiota and recurrent spontaneous abortion. DOI: 10.3389/frph.2026.1801173. PMCID: PMC13233716. PMID: 42253809. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13233716/
- Zalila-Kolsi Imen (2026). Probiotics and the Human Microbiome: Classical Functions, Emerging Systemic Roles, and Future Therapeutic Frontiers. DOI: 10.3390/biology15090665. PMCID: PMC13162965. PMID: 42117804. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13162965/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.